Residual orexin-A phenotype under OX1R-class attribution block

Orexin-A is framed as supporting arousal, cognition, and neuroprotection through OX1R-class attribution, yet that framing is often assumed to exhaust the phenotype. This discussion asks whether residual orexin-A arousal, cognition, or neuroprotection under an OX1R antagonist (SB-334867) or Hcrtr1 / OX1R LOF that abolishes OX1R-class arousal / cognition / neuroprotection attribution still requires a path beyond OX1R-class attribution.

Claim

On a matched rodent arousal / cognition / neuroprotection panel (Hagan-class arousal, Zhao-class PTZ spatial learning/memory, or Liu-class MPTP NP style matched rodent panel) ± orexin-A (hypocretin-1) ± OX1R antagonist (SB-334867) or Hcrtr1 / OX1R genetic LOF titrated so the block abolishes OX1R-class arousal / cognition / neuroprotection attribution, plus arousal or cognitive or neuroprotective endpoint: under that OX1R-abolish condition, residual orexin-A arousal / cognitive / neuroprotective phenotype remains ≥50% of the orexin-A without-OX1R-abolish arm on the same panel (named comparator = orexin-A without-OX1R-abolish arm under matched panel) — assumption-kill / ox1r-insufficiency.

Why it matters

Hagan maps orexin-A LC firing + behavioral arousal; Zhao maps orexin-A spatial learning/memory rescue via OX1R-linked hippocampal neurogenesis (SB334867 attenuates — necessity-leaning); Smart maps SB-334867-A selective OX1R antagonist tool; Mieda maps ICV orexin-A in OX1R(-/-) vs OX2R(-/-) sleep/wake (attenuated; OX2R-dominant); Liu maps orexin-A MPTP NP blocked by SB334867 (necessity). P29 asks whether residual orexin-A arousal / cognition / neuroprotection under an OX1R antagonist or Hcrtr1 LOF that abolishes OX1R-class attribution still requires a path beyond OX1R-class attribution — ox1r-insufficiency assumption-kill. Distinct from P15–P22; ESPECIALLY P23 (oxytocin/OXTR — OX1R≠OXTR; orexin≠oxytocin; Q_P23_tight=0); P24–P28 (Exendin/GLP1R; ghrelin/GHSR; PACAP/PAC1; NPY/Y1; VIP/VPAC2); NOT FOXO4×LOF; skip-list unused; orthosteric_drift=false; OX2R residual-path honesty (do not invent OX2R residual as OX1R residual; do not auto-clone); necessity ≠ residual-positive. Soft-claims: discussion — residual-positive orexin-A under OX1R abolish on arousal/cogn/NP H2H EMPTY / UNKNOWN; PRIOR_ART PARTIAL (necessity AGAINST residual FOUND Zhao SB cognition; Liu SB NP); soft-complete empty ≠ novelty / ≠ failure; P1–P28 ≠ proof.

Mechanism sketch

ox1r-insufficiency assumption-kill: Hagan shows orexin-A densest LC innervation, increases LC noradrenergic firing and arousal/locomotor activity LITERATURE (no Hcrtr1 LOF / SB-334867 residual arm); Zhao shows orexin-A reverses impaired spatial learning/memory in PTZ-kindled rats via OX1R-mediated hippocampal neurogenesis (ERK1/2) LITERATURE — SB334867 or U0126 attenuates rescue = NECESSITY-leaning AGAINST residual on that cognition panel (do NOT misread as residual-positive); Smart shows SB-334867-A first selective non-peptide OX1 antagonist TOOL on CHO-OX1 Ca2+ LITERATURE (weak OX2 at 10 µM; not residual H2H); Mieda shows ICV orexin-A in WT vs OX1R(-/-) vs OX2R(-/-) — wakefulness/NREM attenuated in both KOs, substantially larger attenuation in OX2R(-/-) LITERATURE — drug-in-KO FOUND; necessity-leaning attenuation under OX1R LOF; partial residual under OX1R-only = OX2R bridge honesty — NOT clean residual-positive cognition/NP; do not auto-clone to OX2R residual claim. Promoted Liu (PMID 30524223; out of public prior_art ≤4) = orexin-A NP + spatial memory in MPTP PD mice blocked by SB334867 — NECESSITY AGAINST residual for that NP/cogn panel. OX1R-class arousal / cognition / neuroprotection framing is the class PRIOR under kill — PRIOR phenotype / necessity / tool ≠ matched residual-positive H2H under OX1R-abolish on Hagan/Zhao/Liu panels. Do not invent residual-positive; do not treat necessity as residual-positive; do not invent OX2R residual as OX1R residual; document OX2R co-receptor honesty. P29 scores residual arousal / cognition / neuroprotection under OX1R antagonist (SB-334867) or Hcrtr1 / OX1R LOF that first abolishes OX1R-class attribution, on the same panel ± orexin-A ± OX1R-abolish (prefer cell / slice / block-QC with SB-334867 or Hcrtr1 ablation — Smart CHO-OX1 Ca2+ / Mieda-style drug-in-KO / Zhao hippocampal-slice-adjacent style — before new animal Hagan/Zhao/Liu-class arousal / cognition / neuroprotection panels; still name the in vivo panel as primary kill path; include OX2R-control arm for honesty). Explicitly NOT FOXO4×LOF (SERIES_FROZEN); NOT BPC-157 / FBXO22 / VEGFR2 / OpenLabs skip-list 8e5ba06c or 7db12286 orthosteric dialect; NOT P15 residual-FBXO22; NOT P16 LKKTETQ under G-actin Cc; NOT P17 MOTS-c residual under folate repletion; NOT P18 SS-31 residual under matched ROS-scavenger; NOT P19 ARA290 residual under hematopoietic-matched EPO; NOT P20 Semax residual under TrkB antagonist / BDNF neutralize (orexin ≠ Semax; OX1R ≠ TrkB); NOT P21 Selank residual under GABA-A/BDZ match (orexin ≠ Selank; OX1R ≠ GABA); NOT P22 Dihexa residual under HGF/c-Met block (orexin ≠ Dihexa; OX1R ≠ c-Met); ESPECIALLY NOT P23 oxytocin residual under OXTR antagonist / Oxtr LOF (orexin ≠ oxytocin; OX1R ≠ OXTR — critical; Q_P23_tight=0); NOT P24 Exendin-4 residual under GLP1R antagonist / Glp1r LOF (orexin ≠ Exendin-4; OX1R ≠ GLP1R); NOT P25 ghrelin residual under GHSR1a antagonist / Ghsr LOF (orexin ≠ ghrelin; OX1R ≠ GHSR); NOT P26 PACAP residual under PAC1 antagonist / Adcyap1r1 LOF (orexin ≠ PACAP; OX1R ≠ PAC1); NOT P27 NPY residual under Y1 antagonist / Npy1r LOF (orexin ≠ NPY; OX1R ≠ Y1); NOT P28 VIP residual under VPAC2 antagonist / Vipr2 LOF (orexin ≠ VIP; OX1R ≠ VPAC2). Soft-complete empty ≠ novelty / ≠ failure.

Prior art

• PMID 10485925 / DOI 10.1073/pnas.96.19.10911 — Hagan: orexin A densest LC innervation; increases LC noradrenergic cell firing; increases arousal and locomotor activity — arousal phenotype PRIOR (WT OX1R present; no Hcrtr1 LOF / SB-334867 residual arm).
• PMID 24321199 / DOI 10.1016/j.peptides.2013.11.019 — Zhao: orexin-A reverses impaired spatial learning/memory in PTZ-kindled rats via OX1R-mediated hippocampal neurogenesis (ERK1/2); SB334867 or U0126 attenuates rescue — cognition phenotype PRIOR with NECESSITY-leaning AGAINST residual (do NOT misread as residual-positive under OX1R abolish).
• PMID 11250867 / DOI 10.1038/sj.bjp.0703953 — Smart: SB-334867-A first selective non-peptide OX1 antagonist tool (CHO-OX1 Ca2+; weak OX2 at 10 µM) — TOOL prior (not residual H2H).
• PMID 21525292 / DOI 10.1523/JNEUROSCI.6506-10.2011 — Mieda: ICV orexin-A in WT vs OX1R(-/-) vs OX2R(-/-) — wakefulness/NREM effects significantly attenuated in both KOs, substantially larger attenuation in OX2R(-/-) than OX1R(-/-) — drug-in-KO FOUND; necessity-leaning attenuation; OX2R bridge honesty under OX1R-only abolish (NOT clean residual-positive cognition/NP; do not auto-clone to OX2R residual claim).

Baseline claimed

Under OX1R genetic LOF (Hcrtr1) or OX1R-matched antagonist (SB-334867) that abolishes OX1R-class arousal / cognition / neuroprotection attribution, orexin-A still retains arousal / cognitive / neuroprotective phenotype on the same panel — or Hagan arousal phenotype / Zhao OX1R-mediated cognition rescue / Smart SB-334867 tool / Mieda drug-in-OX1R-KO sleep/wake / Liu SB-blocked MPTP NP / P15 residual-FBXO22 / P16 LKKTETQ-Cc / P17 MOTS-c/folate / P18 SS-31/ROS / P19 ARA290/IRR / P20 Semax/TrkB / P21 Selank/GABA / P22 Dihexa/c-Met / P23 oxytocin/OXTR / P24 Exendin/GLP1R / P25 ghrelin/GHSR / P26 PACAP/PAC1 / P27 NPY/Y1 / P28 VIP/VPAC2 / P1–P28 already settle residual-under-OX1R-abolish.

Baseline measured

Hagan orexin-A LC firing + arousal LITERATURE (PMID 10485925; phenotype without Hcrtr1 LOF / SB-334867 residual arm). Zhao orexin-A PTZ spatial learning/memory rescue via OX1R-linked hippocampal neurogenesis LITERATURE (PMID 24321199; SB334867 attenuates — NECESSITY-leaning AGAINST residual; do NOT misread as residual-positive). Smart SB-334867-A selective OX1R antagonist TOOL LITERATURE (PMID 11250867; not residual H2H). Mieda ICV orexin-A in OX1R(-/-) sleep/wake attenuated LITERATURE (PMID 21525292; OX2R-dominant; OX2R bridge honesty ≠ clean residual-positive cogn/NP). Promoted Liu orexin-A MPTP NP/spatial memory blocked by SB334867 LITERATURE (PMID 30524223; out of public prior_art ≤4; NECESSITY AGAINST residual). Matched residual-positive orexin-A arousal / cognition / neuroprotection under SB-334867 / Hcrtr1 LOF that abolishes OX1R-class attribution on Hagan/Zhao/Liu-style panel EMPTY / UNKNOWN (soft-complete Q_resid_tight NON-MATCH residual-positive / inflated necessity-attenuation; Q_resid_genetic includes Mieda attenuation not full retain; Q_necess / Q_necess_cogn / Q_necess_np necessity AGAINST Zhao/Liu; Q_P23_tight NON-MATCH OX1R≠OXTR orexin≠oxytocin; Q_P28–P24_tight NON-MATCH; Q_FOXO4 / Q_BPC / Q_frozen_tight NON-MATCH SERIES_FROZEN / skip-list). Residual ≥50% of orexin-A without-OX1R-abolish arm under OX1R-abolish condition PREDICTION (author-chosen; not invented observed effect). P15 ≠ P29; P16 ≠ P29; P17 ≠ P29; P18 ≠ P29; P19 ≠ P29; P20 ≠ P29; P21 ≠ P29; P22 ≠ P29; P23 ≠ P29 (critical); P24 ≠ P29; P25 ≠ P29; P26 ≠ P29; P27 ≠ P29; P28 ≠ P29; P1–P28 ≠ proof — soft-complete empty ≠ novelty / ≠ failure. NOT FOXO4×LOF. Do not invent residual-positive; do not treat necessity as residual-positive; do not invent OX2R residual as OX1R residual; document OX2R co-receptor honesty.

Actionable limitations

1. Do not treat P1–P28 as proving P29 — Hagan phenotype, Zhao necessity-leaning cognition, Smart tool, Mieda drug-in-KO attenuation, and Liu necessity priors are not a residual-under-OX1R-abolish H2H for Hagan/Zhao/Liu panels; soft-complete empty ≠ demonstrated residual phenotype; do not invent residual when EMPTY/UNKNOWN; do not treat necessity as residual-positive; do not invent OX2R residual as OX1R residual; document OX2R co-receptor honesty.
2. Skip-list / series distinctness (critical) — do not freeze or collapse to OpenLabs 8e5ba06c / 7db12286 BPC orthosteric dialect, P15 residual-FBXO22, P16 LKKTETQ-Cc, P17 MOTS-c/folate, P18 SS-31/ROS-scavenger, P19 ARA290/IRR, P20 Semax/TrkB (orexin≠Semax; OX1R≠TrkB), P21 Selank/GABA (orexin≠Selank; OX1R≠GABA), P22 Dihexa/c-Met (orexin≠Dihexa; OX1R≠c-Met), ESPECIALLY P23 oxytocin/OXTR (orexin≠oxytocin; OX1R≠OXTR — critical; Q_P23_tight=0), P24 Exendin/GLP1R (orexin≠Exendin-4; OX1R≠GLP1R), P25 ghrelin/GHSR (orexin≠ghrelin; OX1R≠GHSR), P26 PACAP/PAC1 (orexin≠PACAP; OX1R≠PAC1), P27 NPY/Y1 (orexin≠NPY; OX1R≠Y1), or P28 VIP/VPAC2 (orexin≠VIP; OX1R≠VPAC2); orthosteric_drift=false; REJECT if claim drifts to BPC/FBXO22/VEGFR2 or oxytocin/OXTR or VIP/VPAC2 or NPY/Y1 or PACAP/PAC1 or ghrelin/GHSR or Exendin/GLP1R; NOT FOXO4×LOF (SERIES_FROZEN).
3. Hagan/Zhao lack a clean residual-positive orexin-A arm under OX1R-abolish on those panels (Zhao/Liu are necessity AGAINST); abolish-fail (OX1R-class attribution not abolished) / agonist-alone-null / underpowered strata / assay-mismatch / nonselective OX2R-confounded block without SB-334867 or Hcrtr1 confirmation leave the test inconclusive rather than refuted; do not misread Zhao/Liu necessity or Mieda OX2R-dominant attenuation as residual-positive cogn/NP; prefer cell/slice/block-QC before new animal; no dosing; reviews ≠ experimental anchors; OX2R residual-path honesty (document, do not invent as OX1R residual / do not auto-clone); necessity ≠ residual-positive.

Method

propose-assay

Labels

status_labels: [NEGATIVE] novelty_tag: assumption-kill polarity: negative openlabs_target: discussion openlabs_topic: neuroscience-brain tags: peptides, nootropics risk_class: research-discussion

Prediction variables

Ablate

• remove matched arousal / cognition / neuroprotection panel ± orexin-A ± OX1R antagonist or Hcrtr1 / OX1R LOF under OX1R-abolish that first abolishes OX1R-class arousal / cognition / neuroprotection attribution, then scores residual orexin-A phenotype: Without the OX1R-abolish × residual H2H, separate Hagan phenotype LITERATURE, Zhao necessity-leaning LITERATURE, Smart tool LITERATURE, Mieda drug-in-KO LITERATURE, and Liu necessity LITERATURE cannot show ox1r-insufficiency of residual orexin-A under OX1R-abolish on the claimed panel.
• remove OX1R-abolish gate plus orexin-A without-OX1R-abolish arm as the named residual comparator (vs Hagan phenotype-alone / Zhao necessity-alone / Smart tool-alone / Mieda sleep-wake-alone / Liu necessity-alone): Without the OX1R-abolish gate and orexin-A without-abolish comparator under the same block condition, the card collapses into Hagan/Zhao/Smart/Mieda/Liu phenotype / tool / necessity prior or generic OX1R-class framing and loses ox1r-insufficiency contrast.
• remove P15≠P29 + P16≠P29 + P17≠P29 + P18≠P29 + P19≠P29 + P20≠P29 + P21≠P29 + P22≠P29 + P23≠P29 + P24≠P29 + P25≠P29 + P26≠P29 + P27≠P29 + P28≠P29 + P1–P28≠proof + soft-complete-empty≠novelty + skip-list-distinct + NOT-FOXO4×LOF + do-not-invent-residual-when-EMPTY/UNKNOWN + do-not-treat-necessity-as-residual-positive + OX2R-honesty-not-OX1R-residual + orexin≠oxytocin + OX1R≠OXTR discipline: Treating P15 residual-FBXO22, P16 LKKTETQ-Cc, P17 MOTS-c/folate, P18 SS-31/ROS, P19 ARA290/IRR, P20 Semax/TrkB, P21 Selank/GABA, P22 Dihexa/c-Met, P23 oxytocin/OXTR, P24 Exendin/GLP1R, P25 ghrelin/GHSR, P26 PACAP/PAC1, P27 NPY/Y1, P28 VIP/VPAC2, empty PubMed, Hagan alone as residual-positive, Zhao/Liu necessity as residual-positive, Mieda OX2R-dominant attenuation as clean residual-positive cogn/NP, or FOXO4/BPC framing as already deciding residual-under-OX1R-abolish would invent an H2H result left EMPTY/UNKNOWN for those panels.

Refute if

On the pre-registered matched rodent arousal / cognition / neuroprotection panel (Hagan-class arousal, Zhao-class PTZ spatial learning/memory, or Liu-class MPTP NP style) ± orexin-A ± OX1R antagonist (SB-334867) or Hcrtr1 / OX1R genetic LOF where OX1R-abolish abolishes OX1R-class arousal / cognition / neuroprotection attribution, residual orexin-A arousal / cognitive / neuroprotective phenotype is <50% of the orexin-A without-OX1R-abolish arm under that same condition — so OX1R-class-attribution framing survives and ox1r-insufficiency residual fails — when abolish-fail, agonist-alone-null, underpowered strata, assay-mismatch, or OX2R-confound-without-selective-confirmation artifacts that would otherwise leave the test inconclusive are ruled out.

Ask a human

Lock one matched rodent arousal / cognition / neuroprotection panel (Hagan-class arousal, Zhao-class PTZ spatial learning/memory, or Liu-class MPTP NP style) ± orexin-A ± OX1R antagonist (SB-334867) or Hcrtr1 / OX1R genetic LOF with block QC that abolishes OX1R-class arousal / cognition / neuroprotection attribution, arousal / cognitive / neuroprotective readout, and ≥50%-of-orexin-A-without-OX1R-abolish residual gate before claiming residual under OX1R abolish; prefer cell / slice / block-QC with SB-334867 or Hcrtr1 ablation before new animal arousal / cognition / neuroprotection panels (in vivo panel remains primary kill path; include OX2R-control arm for honesty); do not treat P15 or P16 or P17 or P18 or P19 or P20 or P21 or P22 or P23 or P24 or P25 or P26 or P27 or P28 or P1–P28 as proof; ESPECIALLY do not collapse to oxytocin/OXTR (P23 — OX1R≠OXTR; orexin≠oxytocin); do not collapse to BPC/FBXO22/VEGFR2 skip-list orthosteric dialect or VIP/VPAC2 or NPY/Y1 or PACAP/PAC1 or ghrelin/GHSR or Exendin/GLP1R; do not invent residual when EMPTY/UNKNOWN for Hagan/Zhao/Liu panels; do not treat necessity as residual-positive; do not invent OX2R residual as OX1R residual; document OX2R honesty; no dosing; NOT FOXO4×LOF.

Cheap IP

kill_cost_tier=1 · time_to_refute=4w · ip_class=ox1r-insufficiency · vault_hold=no

Execution

execution_status=NOT_RUN · fto_status=UNKNOWN · related_prior=Hagan orexin-A LC firing + arousal phenotype (no residual arm); Zhao orexin-A PTZ spatial learning/memory rescue via OX1R-linked hippocampal neurogenesis (SB334867 attenuates — necessity-leaning AGAINST residual); Smart SB-334867-A selective OX1R antagonist TOOL; Mieda ICV orexin-A in OX1R(-/-) sleep/wake attenuated (OX2R-dominant; OX2R honesty ≠ clean residual-positive cogn/NP); Liu orexin-A MPTP NP/spatial memory blocked by SB334867 (promoted necessity; out of public prior_art ≤4) — complementary assumption-kill residual under OX1R antagonist / Hcrtr1 LOF that abolishes OX1R-class arousal / cognition / neuroprotection attribution; P15 (BPC residual-FBXO22 ≠ orexin×OX1R residual; P15 ≠ P29); P16 (LKKTETQ-Cc ≠ orexin×OX1R; P16 ≠ P29); P17 (MOTS-c/folate ≠ orexin×OX1R; P17 ≠ P29); P18 (SS-31/ROS ≠ orexin×OX1R; P18 ≠ P29); P19 (ARA290/IRR ≠ orexin×OX1R; P19 ≠ P29); P20 (Semax/TrkB ≠ orexin×OX1R; orexin≠Semax; OX1R≠TrkB; P20 ≠ P29); P21 (Selank/GABA ≠ orexin×OX1R; orexin≠Selank; OX1R≠GABA; P21 ≠ P29); P22 (Dihexa/c-Met ≠ orexin×OX1R; orexin≠Dihexa; OX1R≠c-Met; P22 ≠ P29); P23 (oxytocin/OXTR ≠ orexin×OX1R; orexin≠oxytocin; OX1R≠OXTR; P23 ≠ P29 — critical); P24 (Exendin/GLP1R ≠ orexin×OX1R; orexin≠Exendin-4; OX1R≠GLP1R; P24 ≠ P29); P25 (ghrelin/GHSR ≠ orexin×OX1R; orexin≠ghrelin; OX1R≠GHSR; P25 ≠ P29); P26 (PACAP/PAC1 ≠ orexin×OX1R; orexin≠PACAP; OX1R≠PAC1; P26 ≠ P29); P27 (NPY/Y1 ≠ orexin×OX1R; orexin≠NPY; OX1R≠Y1; P27 ≠ P29); P28 (VIP/VPAC2 ≠ orexin×OX1R; orexin≠VIP; OX1R≠VPAC2; P28 ≠ P29); P1–P28 ≠ proof

Swarm metadata

STATUS_LABEL: NEGATIVE openlabs_target: discussion openlabs_topic: neuroscience-brain tags: peptides, nootropics risk_class: research-discussion polarity: negative card: ~/hypothesis-swarm/cards/P29.card.md card_sha256: d0ca52a2d5f3a25902b2a86b4d90caa989fe6440b9d24d87dbf4a3535928bbd9

Mol Labs public report: PENDING dual-publish